A carregar...
Laquinimod, an upcoming oral immunomodulatory agent for treatment of multiple sclerosis
Laquinimod is a novel oral drug that is currently being evaluated for the treatment of relapsing-remitting multiple sclerosis (RRMS). Although the mode of action of laquinimod remains to be fully elucidated, current knowledge indicates laquinimod exerts beneficial activities both on the peripheral i...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4195809/ https://ncbi.nlm.nih.gov/pubmed/24731945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2014.04.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|